Related Experiment Videos
Arginase activity alterations in peripheral blood lymphocytes in the human chronic lymphocytic leukemia
L Konarska1, I Widzyńska, H Zienkiewicz
1Department of Biochemistry and Clinical Chemistry, Institute of Biopharmacy, Medical School, Warsaw, Poland.
Acta Biochimica Polonica
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations.
Diabetes research and clinical practice·2025
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2004
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.
European journal of cancer (Oxford, England : 1990)·2004
Urinary tract infections in diabetes: clinical significance and management approaches.
Acta biochimica Polonica·2026
Gap junction protein connexin 36 proteostatic mechanisms in photoreceptor cells subjected to excitotoxic stress.
Acta biochimica Polonica·2026
Optimization of a TEEDA-based initiation system for SDS-PAGE.
Acta biochimica Polonica·2026
The yields of nucleic acids and proteins extracted from various murine tissue types.
Acta biochimica Polonica·2026
Loss of LRRK2 Protects Against Ox-LDL-Induced Endothelial Oxidative Damage Via NRF2.
Molecular and cellular biology·2026
A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case.
Journal of the Association of Genetic Technologists·2026
Targeting Compensatory AKT Activation Overcomes Resistance to AXL Inhibition in Acute Lymphoblastic Leukemia.
Molecular cancer therapeutics·2026
Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.
Clinical pharmacology and therapeutics·2026
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.
British journal of haematology·2026